1Edward L, Kaplan MD. Recent epidemiology of group A Streptococcal infection in North American and abroad [J].An Overview Pediatrics, 1996;97 (6) :45.
2Passaro DJ, Smitht DS, Hett EC, et al. Invasive group A Streptococcal infection in the San Fransisco Bay area[.J].Epidemiol Infect,2002; 129(3):471.
3Margam J, Chan G, Mohla C. Ten-minute detection of group A Streptococci in pediatric throat swabs[J].Clin Microbial,1995;21 (2):258.
4Iasuda I, Nakanishi K,Yoshizawa N,et al. Graup A streptococcal antigen in the glomemli of children with Henoch-Schordein nephritis[J].Am Kidney Dis,2003;41(2):366.
5Crum NF,Chum HI,Gaylord TG, et al. Group A Streptococcal toxic shock syndrome developing in the third trimester of pregnancy[J].Infect Dis Obstet Gynecol,2002;10(4):209.
4Romero-Steiner S,Frasch CE,Carlone G,et al. Use of op- sonophagocytosis for serological evaluation of pneumococ- cal vaccines [J]. Clin Vaccine Immunol,2006,13(2):165- 169.
5Kim KH, Yu J, Nahm MH. Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies [J]. Clin. Diag. Lab. Immunol, 2003,10(4) :616-621.
6Romero-Steiner S, Frasch C, Concepcion N, et al. Multi- laboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of streptococcus pneumoniae [J]. Clin Diag Lab Immunol,2005,10(6) : 1019-1024.
7Burton RL,Nahm MH. Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneu- mococcal antibodies [J]. Clin Vaccine Immunol,2006,15 (9) : 1004-1009.
8World Health Organization.Meeting Report: WHO Work- shop on Standardization of Pneumococcal Opsonophago- cytie Assay [R]. Geneva: WHO, 2007 : 1-19.
9World Health Organization. Recommendations for the Pro- duction and Control of Pneumococcal Conjugate Vaccines JR]. Geneva:WHO technical report series No. 927,2005: 64-98.
10Schuerman L, Wysocki J,Tejedor JC,et al. Prediction of Pneumococcal Conjugate Vaccine Effectiveness against Invasive Pnettmococcal Disease Using Opsonophagocytic Activity and Antibody Concentrations Determined by Enzyme-Linked Immunosorbent Assay with 22F Adsorp- tion [J]. Clin Vaccine Immunol,2011,18 (12):2161- 2167.
